PACS Stock Risk & Deep Value Analysis
Pacs Group Inc
Healthcare • Medical Care Facilities
DVR Score
out of 10
What You Need to Know About PACS Stock
We analyzed Pacs Group Inc using our deep value framework. Sign in to see our full verdict and DVR Score.
We ran PACS through our deep value framework — analyzing financial health, distress signals, competitive moat, and risk factors. Our risk assessment: Aggressive. Here's what we found.
PACS Risk Analysis & Red Flags
Risk Matrix
Overall
Aggressive
Financial
Medium-High
Market
Medium
Competitive
Medium
Execution
High
Regulatory
High
Upcoming Risk Events
- 📅
Adverse regulatory changes impacting reimbursement rates for post-acute care
- 📅
Significant increases in labor costs due to ongoing healthcare worker shortages
- 📅
Failure to successfully integrate newly acquired facilities leading to operational inefficiencies
- 📅
Rising interest rates increasing borrowing costs for future M&A
Unlock PACS Risk Analysis & Red Flags
Create a free account to see the full analysis
What Does Pacs Group Inc (PACS) Do?
Market Cap
$2.45B
Sector
Healthcare
Industry
Medical Care Facilities
Employees
32,433
PACS Group, Inc., through its subsidiaries, operates skilled nursing facilities and assisted living facilities in the United States. The company also provides senior care and independent facilities. It engages in the acquisition, ownership, and leasing of health care-related properties. The company was founded in 2013 and is based in Farmington, Utah. Skilled Nursing Care Facility
Visit Pacs Group Inc WebsiteInvestment Thesis
Pacs Group is a consolidator in the fragmented post-acute care sector, strategically positioned to capitalize on demographic tailwinds and operational efficiencies. Its 'roll-up' model and proven execution in integrating facilities offer a clear path to significant market share expansion and long-term value creation, despite the inherent risks of an asset-heavy, M&A-driven business.
Is PACS Stock Undervalued?
Unlock the full AI analysis for PACS
Get the complete DVR score, risk analysis, and more
PACS Price Targets & Strategy
12-Month Target
$50.00
Bull Case
$75.00
Bear Case
$25.00
Entry Strategy
Dollar-cost average on pullbacks, ideally between $30-$35, to build a position in anticipation of continued growth.
Exit Strategy
Consider taking partial profits at $60-$70 to de-risk, with a trailing stop-loss set 15% below recent highs to protect capital.
Portfolio Allocation
5% for moderate risk tolerance
Price Targets & Strategy
Upgrade to Premium for price targets and entry/exit strategies
Is PACS Financially Healthy?
Valuation
P/E Ratio
25.85
Price/Book
4.20
Does PACS Have a Competitive Moat?
Sign in to unlockMoat Rating
🛡️ Narrow
Moat Trend
Expanding
Moat Sources
3 Identified
The moat, derived from efficient scale and operational expertise, is durable as long as management continues to execute its acquisition and integration strategy effectively, leveraging scale to achieve cost advantages and maintain high care standards. It is less durable against disruptive technological shifts or major regulatory overhauls.
Moat Erosion Risks
- •Aggressive competition from larger integrated healthcare systems
- •Inability to source and integrate accretive acquisitions at reasonable valuations
- •Rapid increases in labor costs eroding cost advantages
- •Loss of key operational leadership
PACS Competitive Moat Analysis
Sign up to see competitive advantages
PACS Market Intelligence
Sentiment & Insider Activity
Social Sentiment
Neutral
Institutional Sentiment
Positive
Insider Activity (Form 4)
Mixed, with some strategic purchases by management, balanced by expected selling from IPO lock-up expirations.
Options Flow
Moderate call volume, suggesting cautious optimism regarding future growth. No extreme unusual activity observed.
Earnings Intelligence
Next Earnings
2026-05-07 (Estimated for Q1 2026)
Surprise Probability
Medium
Historical Earnings Pattern
Stock tends to react strongly to guidance and acquisition pipeline updates, with less volatility on in-line earnings if the growth narrative remains intact.
Key Metrics to Watch
Competitive Position
Top Competitor
ENSG
Market Share Trend
Gaining
Valuation vs Peers
Trading at a slight premium on forward EV/EBITDA compared to slower-growth post-acute care peers, reflecting its M&A-driven growth strategy and perceived scalability.
Competitive Advantages
- •Proven M&A expertise and integration capabilities
- •Operational excellence and cost management in a complex environment
- •Regional density and scale creating local market efficiencies
Market Intelligence
Get sentiment, earnings intel, and peer analysis with Premium
What Could Drive PACS Stock Higher?
Near-Term (0-6 months)
- •Q1 2026 Earnings Report (Estimated early May 2026)
- •New accretive acquisition announcements expanding geographic footprint
- •Successful integration of recent acquisitions leading to margin improvements
Medium-Term (6-18 months)
- •Strategic partnerships with major health systems or payers
- •Refinancing of existing debt at more favorable rates
- •Demonstrable organic growth within existing facilities improving occupancy and revenue per patient day
Long-Term (18+ months)
- •Establishment of dominant regional market leadership in key demographics
- •Innovation in value-based care models, enhancing revenue streams and patient outcomes
- •Sustained operating leverage leading to significant free cash flow generation
Catalysts & Growth Drivers
Upgrade to Premium to see catalysts
What's the Bull Case for PACS?
- ✓
Acceleration in accretive acquisition pace and successful integration metrics
- ✓
Stable to improving EBITDA margins despite labor cost pressures
- ✓
Prudent management of debt-to-EBITDA ratios
- ✓
Favorable regulatory developments regarding reimbursement policies
Bull Case Analysis
See what could go right with Premium
Competing with PACS
See how Pacs Group Inc compares to related companies
| Company | Market Cap | DVR Score | P/E | Revenue | Profit Margin | Rev Growth | |
|---|---|---|---|---|---|---|---|
Pacs Group Inc PACS | $2.4B | 6.7 | 25.9 | — | — | — | |
Johnson & Johnson JNJ | — | 1.0 | — | — | — | — | Compare → |
Pfizer Inc PFE | $161.1B | 0.2 | 20.2 | $17.6B | 12.4% | -1.7% | Compare → |
UnitedHealth Group Inc UNH | $300.6B | 0.5 | 17.3 | — | — | — | Compare → |
📊 Explore More Stock Analysis
Get comprehensive Deep Value Reports for thousands of stocks. Research risk, financial health, and investment potential with our AI-powered analysis.
FAQ
What is the DVR Score for Pacs Group Inc (PACS)?
As of March 21, 2026, Pacs Group Inc has a DVR Score of 6.7 out of 10, placing it in the "Solid Pick" category. This score is generated by our AI-powered deep value analysis framework that evaluates growth potential, financial health, competitive moat, and risk factors.
What is the market capitalization of Pacs Group Inc?
Pacs Group Inc's market capitalization is approximately $2.4B. The company operates in the Healthcare sector within the Medical Care Facilities industry.
What ticker symbol does Pacs Group Inc use?
PACS is the ticker symbol for Pacs Group Inc. The company trades on the NYQ.
What is the risk level for PACS stock?
Our analysis rates Pacs Group Inc's overall risk as Aggressive. This assessment considers execution risk, market risk, financial risk, competitive risk, and regulatory risk. For a full breakdown, see the risk analysis section above.
What is the P/E ratio of PACS?
Pacs Group Inc currently has a price-to-earnings (P/E) ratio of 25.9. This is in line with broader market averages.
How often is the PACS DVR analysis updated?
Our AI-powered analysis of Pacs Group Inc is refreshed regularly to incorporate the latest financial data, market conditions, and news. The most recent update was on March 21, 2026.
Important Disclaimer – Not Financial Advice
Deep Value Reports is an independent research platform for educational and informational purposes only. We are not financial advisors, investment advisors, or licensed professionals. The analysis, scores, and information provided on this page for PACS (Pacs Group Inc) should not be construed as personalized investment advice, a recommendation to buy or sell any security, or an offer to provide investment advisory services.
All investments involve risk, including the potential loss of principal. Past performance does not guarantee future results. Always conduct your own research, consider your financial situation, and consult with a qualified financial advisor before making any investment decisions.